[21 hydroxylase deficiency: new strategies emerging from molecular studies].
Morel
Y
Y
Laboratoire de biochimie endocrinienne et moléculaire, hôpital Debrousse, 69322 Lyon Cedex 05 et EA 3739, université Claude Bernard-Lyon I.
Tardy
V
V
Costa
J-M
JM
Forest
M G
MG
David
M
M
D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis* / Q000201:enzymology / Q000235:genetics; D019943:Amino Acid Substitution; D019090:Case Management; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D005808:Genes, Recessive; D006580:Genetic Carrier Screening; D005817:Genetic Counseling; D006801:Humans; D017354:Point Mutation; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013255:Steroid 21-Hydroxylase / Q000235:genetics*; D014770:Virilism / Q000209:etiology / Q000517:prevention & control
D003907:Dexamethasone; D013255:Steroid 21-Hydroxylase